Global Gemcitabine Injection Market Research Report 2021

1 Gemcitabine Injection Market Overview
1.1 Product Overview and Scope of Gemcitabine Injection
1.2 Gemcitabine Injection Segment by Dosage Form & Strength Type
1.2.1 Global Gemcitabine Injection Sales Growth Rate Comparison by Dosage Form & Strength Type (2021-2027)
1.2.2 200mg/5.26 mL
1.2.3 1g/26.3 mL
1.2.4 2g/52.6 mL
1.3 Gemcitabine Injection Segment by Application
1.3.1 Global Gemcitabine Injection Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Gemcitabine Injection Market Size Estimates and Forecasts
1.4.1 Global Gemcitabine Injection Revenue 2016-2027
1.4.2 Global Gemcitabine Injection Sales 2016-2027
1.4.3 Gemcitabine Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gemcitabine Injection Market Competition by Manufacturers
2.1 Global Gemcitabine Injection Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gemcitabine Injection Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gemcitabine Injection Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gemcitabine Injection Manufacturing Sites, Area Served, Product Type
2.5 Gemcitabine Injection Market Competitive Situation and Trends
2.5.1 Gemcitabine Injection Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gemcitabine Injection Players Market Share by Revenue
2.5.3 Global Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gemcitabine Injection Retrospective Market Scenario by Region
3.1 Global Gemcitabine Injection Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Gemcitabine Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Gemcitabine Injection Market Facts & Figures by Country
3.3.1 North America Gemcitabine Injection Sales by Country
3.3.2 North America Gemcitabine Injection Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Gemcitabine Injection Market Facts & Figures by Country
3.4.1 Europe Gemcitabine Injection Sales by Country
3.4.2 Europe Gemcitabine Injection Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gemcitabine Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Gemcitabine Injection Sales by Region
3.5.2 Asia Pacific Gemcitabine Injection Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Gemcitabine Injection Market Facts & Figures by Country
3.6.1 Latin America Gemcitabine Injection Sales by Country
3.6.2 Latin America Gemcitabine Injection Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gemcitabine Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Gemcitabine Injection Sales by Country
3.7.2 Middle East and Africa Gemcitabine Injection Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gemcitabine Injection Historic Market Analysis by Dosage Form & Strength Type
4.1 Global Gemcitabine Injection Sales Market Share by Dosage Form & Strength Type (2016-2021)
4.2 Global Gemcitabine Injection Revenue Market Share by Dosage Form & Strength Type (2016-2021)
4.3 Global Gemcitabine Injection Price by Dosage Form & Strength Type (2016-2021)

5 Global Gemcitabine Injection Historic Market Analysis by Application
5.1 Global Gemcitabine Injection Sales Market Share by Application (2016-2021)
5.2 Global Gemcitabine Injection Revenue Market Share by Application (2016-2021)
5.3 Global Gemcitabine Injection Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Corporation Information
6.1.2 Fresenius Kabi Description and Business Overview
6.1.3 Fresenius Kabi Gemcitabine Injection Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Fresenius Kabi Gemcitabine Injection Product Portfolio
6.1.5 Fresenius Kabi Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Gemcitabine Injection Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Pharmaceuticals Gemcitabine Injection Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Gemcitabine Injection Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Gemcitabine Injection Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Mylan Inc
6.4.1 Mylan Inc Corporation Information
6.4.2 Mylan Inc Description and Business Overview
6.4.3 Mylan Inc Gemcitabine Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Inc Gemcitabine Injection Product Portfolio
6.4.5 Mylan Inc Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Gemcitabine Injection Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis AG Gemcitabine Injection Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Gemcitabine Injection Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Accord Healthcare Gemcitabine Injection Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 Meitheal Pharmaceuticals
6.6.1 Meitheal Pharmaceuticals Corporation Information
6.6.2 Meitheal Pharmaceuticals Description and Business Overview
6.6.3 Meitheal Pharmaceuticals Gemcitabine Injection Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Meitheal Pharmaceuticals Gemcitabine Injection Product Portfolio
6.7.5 Meitheal Pharmaceuticals Recent Developments/Updates

7 Gemcitabine Injection Manufacturing Cost Analysis
7.1 Gemcitabine Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gemcitabine Injection
7.4 Gemcitabine Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gemcitabine Injection Distributors List
8.3 Gemcitabine Injection Customers

9 Gemcitabine Injection Market Dynamics
9.1 Gemcitabine Injection Industry Trends
9.2 Gemcitabine Injection Growth Drivers
9.3 Gemcitabine Injection Market Challenges
9.4 Gemcitabine Injection Market Restraints

10 Global Market Forecast
10.1 Gemcitabine Injection Market Estimates and Projections by Dosage Form & Strength Type
10.1.1 Global Forecasted Sales of Gemcitabine Injection by Dosage Form & Strength Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gemcitabine Injection by Dosage Form & Strength Type (2022-2027)
10.2 Gemcitabine Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gemcitabine Injection by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gemcitabine Injection by Application (2022-2027)
10.3 Gemcitabine Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gemcitabine Injection by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gemcitabine Injection by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Gemcitabine Injection Sales (KL) Growth Rate Comparison by Dosage Form & Strength Type (2021-2027)
Table 2. Global Gemcitabine Injection Sales (KL) Comparison by Application (2021-2027)
Table 3. Global Gemcitabine Injection Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Gemcitabine Injection Covered in This Study
Table 5. Global Gemcitabine Injection Sales (KL) of Key Manufacturers (2016-2021)
Table 6. Global Gemcitabine Injection Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Gemcitabine Injection Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Gemcitabine Injection Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Gemcitabine Injection Average Price (US$/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Gemcitabine Injection Manufacturing Sites and Area Served
Table 11. Manufacturers Gemcitabine Injection Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gemcitabine Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gemcitabine Injection as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gemcitabine Injection Sales by Region (2016-2021) & (KL)
Table 16. Global Gemcitabine Injection Sales Market Share by Region (2016-2021)
Table 17. Global Gemcitabine Injection Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Gemcitabine Injection Sales by Country (2016-2021) & (KL)
Table 19. North America Gemcitabine Injection Sales Market Share by Country (2016-2021)
Table 20. North America Gemcitabine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Gemcitabine Injection Revenue Market Share by Country (2016-2021)
Table 22. Europe Gemcitabine Injection Sales by Country (2016-2021) & (KL)
Table 23. Europe Gemcitabine Injection Sales Market Share by Country (2016-2021)
Table 24. Europe Gemcitabine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Gemcitabine Injection Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Gemcitabine Injection Sales by Region (2016-2021) & (KL)
Table 27. Asia Pacific Gemcitabine Injection Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Gemcitabine Injection Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Gemcitabine Injection Revenue Market Share by Region (2016-2021)
Table 30. Latin America Gemcitabine Injection Sales by Country (2016-2021) & (KL)
Table 31. Latin America Gemcitabine Injection Sales Market Share by Country (2016-2021)
Table 32. Latin America Gemcitabine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Gemcitabine Injection Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Gemcitabine Injection Sales by Country (2016-2021) & (KL)
Table 35. Middle East and Africa Gemcitabine Injection Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Gemcitabine Injection Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Gemcitabine Injection Revenue Market Share by Country (2016-2021)
Table 38. Global Gemcitabine Injection Sales (KL) by Dosage Form & Strength Type (2016-2021)
Table 39. Global Gemcitabine Injection Sales Market Share by Dosage Form & Strength Type (2016-2021)
Table 40. Global Gemcitabine Injection Revenue (Million US$) by Dosage Form & Strength Type (2016-2021)
Table 41. Global Gemcitabine Injection Revenue Share by Dosage Form & Strength Type (2016-2021)
Table 42. Global Gemcitabine Injection Price (US$/L) by Dosage Form & Strength Type (2016-2021)
Table 43. Global Gemcitabine Injection Sales (KL) by Application (2016-2021)
Table 44. Global Gemcitabine Injection Sales Market Share by Application (2016-2021)
Table 45. Global Gemcitabine Injection Revenue (Million US$) by Application (2016-2021)
Table 46. Global Gemcitabine Injection Revenue Share by Application (2016-2021)
Table 47. Global Gemcitabine Injection Price (US$/L) by Application (2016-2021)
Table 48. Fresenius Kabi Corporation Information
Table 49. Fresenius Kabi Description and Business Overview
Table 50. Fresenius Kabi Gemcitabine Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 51. Fresenius Kabi Gemcitabine Injection Product
Table 52. Fresenius Kabi Recent Developments/Updates
Table 53. Teva Pharmaceuticals Corporation Information
Table 54. Teva Pharmaceuticals Description and Business Overview
Table 55. Teva Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 56. Teva Pharmaceuticals Gemcitabine Injection Product
Table 57. Teva Pharmaceuticals Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Gemcitabine Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 61. Pfizer Gemcitabine Injection Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Mylan Inc Corporation Information
Table 64. Mylan Inc Description and Business Overview
Table 65. Mylan Inc Gemcitabine Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 66. Mylan Inc Gemcitabine Injection Product
Table 67. Mylan Inc Recent Developments/Updates
Table 68. Novartis AG Corporation Information
Table 69. Novartis AG Description and Business Overview
Table 70. Novartis AG Gemcitabine Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 71. Novartis AG Gemcitabine Injection Product
Table 72. Novartis AG Recent Developments/Updates
Table 73. Accord Healthcare Corporation Information
Table 74. Accord Healthcare Description and Business Overview
Table 75. Accord Healthcare Gemcitabine Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 76. Accord Healthcare Gemcitabine Injection Product
Table 77. Accord Healthcare Recent Developments/Updates
Table 78. Meitheal Pharmaceuticals Corporation Information
Table 79. Meitheal Pharmaceuticals Description and Business Overview
Table 80. Meitheal Pharmaceuticals Gemcitabine Injection Sales (KL), Revenue (Million US$), Price (US$/L) and Gross Margin (2016-2021)
Table 81. Meitheal Pharmaceuticals Gemcitabine Injection Product
Table 82. Meitheal Pharmaceuticals Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Gemcitabine Injection Distributors List
Table 86. Gemcitabine Injection Customers List
Table 87. Gemcitabine Injection Market Trends
Table 88. Gemcitabine Injection Growth Drivers
Table 89. Gemcitabine Injection Market Challenges
Table 90. Gemcitabine Injection Market Restraints
Table 91. Global Gemcitabine Injection Sales Forecast by Dosage Form & Strength Type (2022-2027) & (KL)
Table 92. Global Gemcitabine Injection Sales Market Share Forecast by Dosage Form & Strength Type (2022-2027)
Table 93. Global Gemcitabine Injection Revenue Forecast by Dosage Form & Strength Type (2022-2027) & (US$ Million)
Table 94. Global Gemcitabine Injection Revenue Market Share Forecast by Dosage Form & Strength Type (2022-2027)
Table 95. Global Gemcitabine Injection Sales Forecast by Application (2022-2027) & (KL)
Table 96. Global Gemcitabine Injection Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Gemcitabine Injection Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Gemcitabine Injection Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Gemcitabine Injection Sales Forecast by Region (2022-2027) & (KL)
Table 100. Global Gemcitabine Injection Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Gemcitabine Injection Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Gemcitabine Injection Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gemcitabine Injection
Figure 2. Global Gemcitabine Injection Market Share by Dosage Form & Strength Type in 2020 & 2027
Figure 3. 200mg/5.26 mL Product Picture
Figure 4. 1g/26.3 mL Product Picture
Figure 5. 2g/52.6 mL Product Picture
Figure 6. Global Gemcitabine Injection Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Global Gemcitabine Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Gemcitabine Injection Market Size 2016-2027 (US$ Million)
Figure 11. Global Gemcitabine Injection Sales 2016-2027 (KL)
Figure 12. Global Gemcitabine Injection Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Gemcitabine Injection Sales Share by Manufacturers in 2020
Figure 14. Global Gemcitabine Injection Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Gemcitabine Injection Players: Market Share by Revenue in 2020
Figure 16. Gemcitabine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Gemcitabine Injection Sales Market Share by Region (2016-2021)
Figure 18. Global Gemcitabine Injection Sales Market Share by Region in 2020
Figure 19. Global Gemcitabine Injection Revenue Market Share by Region (2016-2021)
Figure 20. Global Gemcitabine Injection Revenue Market Share by Region in 2020
Figure 21. United States Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Gemcitabine Injection Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Gemcitabine Injection by Dosage Form & Strength Type (2016-2021)
Figure 44. Sales Market Share of Gemcitabine Injection by Application (2016-2021)
Figure 45. Sales Market Share of Gemcitabine Injection by Application in 2020
Figure 46. Revenue Share of Gemcitabine Injection by Application (2016-2021)
Figure 47. Revenue Share of Gemcitabine Injection by Application in 2020
Figure 48. Manufacturing Cost Structure of Gemcitabine Injection
Figure 49. Manufacturing Process Analysis of Gemcitabine Injection
Figure 50. Gemcitabine Injection Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.